Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Taquet M; Skorniewska Z; Hampshire A; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Raman B; Leavy OC; Richardson M; Elneima O; McAuley HJC; Shikotra A; Singapuri A; Sereno M; Saunders RM; Harris VC; Houchen-Wolloff L; Greening NJ; Mansoori P; Harrison EM; Docherty AB; Lone NI; Quint J; Sattar N; Brightling CE; Wain LV; Evans RE; Geddes JR; Harrison PJ; PHOSP-COVID Study Collaborative Group.
Nat Med
(Unknown)
Published: 2023
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma.
Lee H; Ahn S; Maity R; Leblay N; Ziccheddu B; Truger M; Chojnacka M; Cirrincione A; Durante M; Tilmont R; Barakat E; Poorebrahim M; Sinha S; McIntyre J; M Y Chan A; Wilson H; Kyman S; Krishnan A; Landgren O; Walter W; Meggendorfer M; Haferlach C; Haferlach T; Einsele H; Kortüm MK; Knop S; Alberge JB; Rosenwald A; Keats JJ; Rasche L; Maura F; Neri P; Bahlis NJ.
Nat Med
(Unknown)
Published: 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Branche AR; Rouphael NG; Diemert DJ; Falsey AR; Losada C; Baden LR; Frey SE; Whitaker JA; Little SJ; Anderson EJ; Walter EB; Novak RM; Rupp R; Jackson LA; Babu TM; Kottkamp AC; Luetkemeyer AF; Immergluck LC; Presti RM; Bäcker M; Winokur PL; Mahgoub SM; Goepfert PA; Fusco DN; Malkin E; Bethony JM; Walsh EE; Graciaa DS; Samaha H; Sherman AC; Walsh SR; Abate G; Oikonomopoulou Z; El Sahly HM; Martin TCS; Kamidani S; Smith MJ; Ladner BG; Porterfield L; Dunstan M; Wald A; Davis T; Atmar RL; Mulligan MJ; Lyke KE; Posavad CM; Meagher MA; Stephens DS; Neuzil KM; Abebe K; Hill H; Albert J; Telu K; Mu J; Lewis TC; Giebeig LA; Eaton A; Netzl A; Wilks SH; Türeli S; Makhene M; Crandon S; Montefiori DC; Makowski M; Smith DJ; Nayak SU; Roberts PC; Beigel JH; COVAIL Study Group.
Nat Med
(Unknown)
Published: 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts.
Watts GF; Schwabe C; Scott R; Gladding PA; Sullivan D; Baker J; Clifton P; Hamilton J; Given B; Melquist S; Zhou R; Chang T; San Martin J; Gaudet D; Goldberg IJ; Knowles JW; Hegele RA; Ballantyne CM.
Nat Med
(Unknown)
Published: 2023
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.
Lin Y; Raje NS; Berdeja JG; Siegel DS; Jagannath S; Madduri D; Liedtke M; Rosenblatt J; Maus MV; Massaro M; Petrocca F; Yeri A; Finney O; Caia A; Yang Z; Martin N; Campbell TB; Rytlewski J; Fuller J; Hege K; Munshi NC; Kochenderfer JN.
Nat Med
(Unknown)
Published: 2023
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.
Lesokhin AM; Tomasson MH; Arnulf B; Bahlis NJ; Miles Prince H; Niesvizky R; Rodrίguez-Otero P; Martinez-Lopez J; Koehne G; Touzeau C; Jethava Y; Quach H; Depaus J; Yokoyama H; Gabayan AE; Stevens DA; Nooka AK; Manier S; Raje N; Iida S; Raab MS; Searle E; Leip E; Sullivan ST; Conte U; Elmeliegy M; Czibere A; Viqueira A; Mohty M.
Nat Med
(Unknown)
Published: 2023
Cerebellar deep brain stimulation for chronic post-stroke motor rehabilitation: a phase I trial.
Baker KB; Plow EB; Nagel S; Rosenfeldt AB; Gopalakrishnan R; Clark C; Wyant A; Schroedel M; Ozinga J; Davidson S; Hogue O; Floden D; Chen J; Ford PJ; Sankary L; Huang X; Cunningham DA; DiFilippo FP; Hu B; Jones SE; Bethoux F; Wolf SL; Chae J; Machado AG.
Nat Med
(Unknown)
Published: 2023
Daratumumab monotherapy for refractory lupus nephritis.
Roccatello D; Fenoglio R; Caniggia I; Kamgaing J; Naretto C; Cecchi I; Rubini E; Rossi D; De Simone E; Del Vecchio G; Cozzi M; Sciascia S.
Nat Med
(Unknown)
Published: 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.
Johnson ECB; Bian S; Haque RU; Carter EK; Watson CM; Gordon BA; Ping L; Duong DM; Epstein MP; McDade E; Barthélemy NR; Karch CM; Xiong C; Cruchaga C; Perrin RJ; Wingo AP; Wingo TS; Chhatwal JP; Day GS; Noble JM; Berman SB; Martins R; Graff-Radford NR; Schofield PR; Ikeuchi T; Mori H; Levin J; Farlow M; Lah JJ; Haass C; Jucker M; Morris JC; Benzinger TLS; Roberts BR; Bateman RJ; Fagan AM; Seyfried NT; Levey AI; Dominantly Inherited Alzheimer Network.
Nat Med
(Unknown)
Published: 2023
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase…
Shah MA; Shitara K; Ajani JA; Bang YJ; Enzinger P; Ilson D; Lordick F; Van Cutsem E; Gallego Plazas J; Huang J; Shen L; Oh SC; Sunpaweravong P; Soo Hoo HF; Turk HM; Oh M; Park JW; Moran D; Bhattacharya P; Arozullah A; Xu RH.
Nat Med
(Unknown)
Published: 2023
A prognostic risk score for development and spread of chronic pain.
Tanguay-Sabourin C; Fillingim M; Guglietti GV; Zare A; Parisien M; Norman J; Sweatman H; Da-Ano R; Heikkala E; PREVENT-AD Research Group; Perez J; Karppinen J; Villeneuve S; Thompson SJ; Martel MO; Roy M; Diatchenko L; Vachon-Presseau E.
Nat Med
(Unknown)
Published: 2023
Phenotypic effects of genetic variants associated with autism.
Rolland T; Cliquet F; Anney RJL; Moreau C; Traut N; Mathieu A; Huguet G; Duan J; Warrier V; Portalier S; Dry L; Leblond CS; Douard E; Amsellem F; Malesys S; Maruani A; Toro R; Børglum AD; Grove J; Baron-Cohen S; Packer A; Chung WK; Jacquemont S; Delorme R; Bourgeron T.
Nat Med
(Unknown)
Published: 2023
Clonal hematopoiesis is associated with protection from Alzheimer's disease.
Bouzid H; Belk JA; Jan M; Qi Y; Sarnowski C; Wirth S; Ma L; Chrostek MR; Ahmad H; Nachun D; Yao W; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; Beiser A; Bick AG; Bis JC; Fornage M; Longstreth WT; Lopez OL; Natarajan P; Psaty BM; Satizabal CL; Weinstock J; Larson EB; Crane PK; Keene CD; Seshadri S; Satpathy AT; Montine TJ; Jaiswal S.
Nat Med
(Unknown)
Published: 2023
An integrated cell atlas of the lung in health and disease.
Sikkema L; Ramírez-Suástegui C; Strobl DC; Gillett TE; Zappia L; Madissoon E; Markov NS; Zaragosi LE; Ji Y; Ansari M; Arguel MJ; Apperloo L; Banchero M; Bécavin C; Berg M; Chichelnitskiy E; Chung MI; Collin A; Gay ACA; Gote-Schniering J; Hooshiar Kashani B; Inecik K; Jain M; Kapellos TS; Kole TM; Leroy S; Mayr CH; Oliver AJ; von Papen M; Peter L; Taylor CJ; Walzthoeni T; Xu C; Bui LT; De Donno C; Dony L; Faiz A; Guo M; Gutierrez AJ; Heumos L; Huang N; Ibarra IL; Jackson ND; Kadur Lakshminarasimha Murthy P; Lotfollahi M; Tabib T; Talavera-López C; Travaglini KJ; Wilbrey-Clark A; Worlock KB; Yoshida M; Lung Biological Network Consortium; van den Berge M; Bossé Y; Desai TJ; Eickelberg O; Kaminski N; Krasnow MA; Lafyatis R; Nikolic MZ; Powell JE; Rajagopal J; Rojas M; Rozenblatt-Rosen O; Seibold MA; Sheppard D; Shepherd DP; Sin DD; Timens W; Tsankov AM; Whitsett J; Xu Y; Banovich NE; Barbry P; Duong TE; Falk CS; Meyer KB; Kropski JA; Pe'er D; Schiller HB; Tata PR; Schultze JL; Teichmann SA; Misharin AV; Nawijn MC; Luecken MD; Theis FJ.
Nat Med
(Unknown)
Published: 2023
Integrated multi-omics for rapid rare disease diagnosis on a national scale.
Lunke S; Bouffler SE; Patel CV; Sandaradura SA; Wilson M; Pinner J; Hunter MF; Barnett CP; Wallis M; Kamien B; Tan TY; Freckmann ML; Chong B; Phelan D; Francis D; Kassahn KS; Ha T; Gao S; Arts P; Jackson MR; Scott HS; Eggers S; Rowley S; Boggs K; Rakonjac A; Brett GR; de Silva MG; Springer A; Ward M; Stallard K; Simons C; Conway T; Halman A; Van Bergen NJ; Sikora T; Semcesen LN; Stroud DA; Compton AG; Thorburn DR; Bell KM; Sadedin S; North KN; Christodoulou J; Stark Z.
Nat Med
(Unknown)
Published: 2023
Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized…
Haney M; Vallée M; Fabre S; Collins Reed S; Zanese M; Campistron G; Arout CA; Foltin RW; Cooper ZD; Kearney-Ramos T; Metna M; Justinova Z; Schindler C; Hebert-Chatelain E; Bellocchio L; Cathala A; Bari A; Serrat R; Finlay DB; Caraci F; Redon B; Martín-García E; Busquets-Garcia A; Matias I; Levin FR; Felpin FX; Simon N; Cota D; Spampinato U; Maldonado R; Shaham Y; Glass M; Thomsen LL; Mengel H; Marsicano G; Monlezun S; Revest JM; Piazza PV.
Nat Med
(Unknown)
Published: 2023
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Okuzumi A; Hatano T; Matsumoto G; Nojiri S; Ueno SI; Imamichi-Tatano Y; Kimura H; Kakuta S; Kondo A; Fukuhara T; Li Y; Funayama M; Saiki S; Taniguchi D; Tsunemi T; McIntyre D; Gérardy JJ; Mittelbronn M; Kruger R; Uchiyama Y; Nukina N; Hattori N.
Nat Med
(Unknown)
Published: 2023
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease.
Bellaver B; Povala G; Ferreira PCL; Ferrari-Souza JP; Leffa DT; Lussier FZ; Benedet AL; Ashton NJ; Triana-Baltzer G; Kolb HC; Tissot C; Therriault J; Servaes S; Stevenson J; Rahmouni N; Lopez OL; Tudorascu DL; Villemagne VL; Ikonomovic MD; Gauthier S; Zimmer ER; Zetterberg H; Blennow K; Aizenstein HJ; Klunk WE; Snitz BE; Maki P; Thurston RC; Cohen AD; Ganguli M; Karikari TK; Rosa-Neto P; Pascoal TA.
Nat Med
(Unknown)
Published: 2023